Skip to content
Screener

IDEAYA Biosciences, Inc. IDYA Total Operating Expenses

Total Operating Expenses at other companies

Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%
Eikon Therapeutics, Inc. logo
Eikon Therapeutics, Inc.EIKN
$87.34M+22.3%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$137M-18.5%
Immunome logo
ImmunomeIMNM
$59.33M+24.7%
Erasca, Inc. logo
Erasca, Inc.ERAS
$187.91M+427%
Nuvation Bio logo
Nuvation BioNUVB
$82.72M+20.9%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.49B+68.5%
Enterprise value$3.36B+69.4%
P/S15×+10.3×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206357
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Operating expenses
Research and development95,72670,886
General and administrative19,37813,503
Total operating expenses115,10484,389
Loss from operations(108,544)(84,389)
Other income
Interest income and other income, net10,00512,211
Net loss$(98,539)$(72,178)

Item 1. Financial Statements (UNAUDITED).

FAQ

What is IDEAYA Biosciences, Inc.'s total operating expenses?
IDEAYA Biosciences, Inc. (IDYA) reported total operating expenses of $115.1M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s total operating expenses changed year-over-year?
IDEAYA Biosciences, Inc.'s total operating expenses increased by 36.4% year-over-year, from $84.39M to $115.1M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s total operating expenses?
Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s total operating expenses has grown at a 48.3% compound annual growth rate (CAGR), from $78.21M to $378.02M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about IDEAYA Biosciences, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude